174 related articles for article (PubMed ID: 7747277)
1. Effects of flumethrin on hepatic drug-metabolizing enzymes and antipyrine disposition in rats.
Anadón A; Martinez-Larrañaga MR; Diaz MJ; Bringas P; Fernandez MC; Martinez MA; Fernandez-Cruz ML
Toxicol Appl Pharmacol; 1995 May; 132(1):14-8. PubMed ID: 7747277
[TBL] [Abstract][Full Text] [Related]
2. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
3. Differential induction of cytochrome P450 isoforms and peroxisomal proliferation by cyfluthrin in male Wistar rats.
Anadón A; Martínez MA; Martínez M; Castellano V; Ares I; Romero A; Fernández R; Martínez-Larrañaga MR
Toxicol Lett; 2013 Jul; 220(2):135-42. PubMed ID: 23639246
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent effects of Klebsiella pneumoniae endotoxin on hepatic drug-metabolizing enzyme activity in rats.
Nadai M; Sekido T; Matsuda I; Li W; Kitaichi K; Itoh A; Nabeshima T; Hasegawa T
J Pharm Pharmacol; 1998 Aug; 50(8):871-9. PubMed ID: 9751451
[TBL] [Abstract][Full Text] [Related]
5. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
[TBL] [Abstract][Full Text] [Related]
6. Effect of deltamethrin on antipyrine pharmacokinetics and metabolism in rat.
Anadón A; Martinez-Larrañaga MR; Díaz MJ; Bringas P; Fernandez MC
Arch Toxicol; 1991; 65(2):156-9. PubMed ID: 2059156
[TBL] [Abstract][Full Text] [Related]
7. Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine.
Sharer JE; Wrighton SA
Drug Metab Dispos; 1996 Apr; 24(4):487-94. PubMed ID: 8801065
[TBL] [Abstract][Full Text] [Related]
8. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
Danhof M; Krom DP; Breimer DD
Xenobiotica; 1979 Nov; 9(11):695-702. PubMed ID: 119355
[TBL] [Abstract][Full Text] [Related]
9. Antipyrine elimination and hepatic microsomal enzyme activity in patients with liver disease.
Wensing G; Ohnhaus EE; Hoensch HP
Clin Pharmacol Ther; 1990 Jun; 47(6):698-705. PubMed ID: 2113450
[TBL] [Abstract][Full Text] [Related]
10. The suppressive effects of lipopolysaccharide-induced acute phase response on hepatic cytochrome P450-dependent drug metabolism in rabbits.
Saitoh T; Kokue E; Shimoda M
J Vet Pharmacol Ther; 1999 Apr; 22(2):87-95. PubMed ID: 10372593
[TBL] [Abstract][Full Text] [Related]
11. Effect of fusidic acid on the hepatic cytochrome P450 enzyme system.
Reimann G; Barthel B; Rockstroh JK; Spatz D; Brockmeyer NH
Int J Clin Pharmacol Ther; 1999 Nov; 37(11):562-6. PubMed ID: 10584978
[TBL] [Abstract][Full Text] [Related]
12. Studies on the metabolism of aminopyrine, antipyrine and theophylline using monoclonal antibodies to cytochrome P-450 isozymes purified from rat liver.
Slusher LB; Park SS; Gelboin HV; Vesell ES
Biochem Pharmacol; 1987 Jul; 36(14):2359-67. PubMed ID: 2440440
[TBL] [Abstract][Full Text] [Related]
13. Induction of cytochrome P-450 and related drug-oxidizing activities in muscone (3-methylcyclopentadecanone)-treated rats.
Tanaka E; Kurata N; Kohno M; Yoshida T; Kuroiwa Y
Biochem Pharmacol; 1987 Dec; 36(24):4263-7. PubMed ID: 3689452
[TBL] [Abstract][Full Text] [Related]
14. Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymes. Specificity for cytochrome P-450.
Spaethe SM; Jollow DJ
Biochem Pharmacol; 1989 Jun; 38(12):2027-38. PubMed ID: 2742604
[TBL] [Abstract][Full Text] [Related]
15. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
Szakács T; Veres Z; Vereczkey L
Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
[TBL] [Abstract][Full Text] [Related]
16. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo.
Teunissen MW; Joeres RP; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Apr; 13(4):223-31. PubMed ID: 6624137
[TBL] [Abstract][Full Text] [Related]
17. [Isoniazid and rifampicin in the rabbit. Effect on hepatic microsomal enzyme activity].
Kergueris MF; Larousse C; Le Normand Y; Guillerme G; Bourin M
J Pharmacol; 1982; 13(4):525-34. PubMed ID: 7154665
[TBL] [Abstract][Full Text] [Related]
18. Studies on in vitro antipyrine metabolism by 13C,15N double labeled method.
Nakagawa A; Nakamura K; Maeda K; Kamataki T; Kato R
Life Sci; 1987 Jul; 41(2):133-43. PubMed ID: 3298908
[TBL] [Abstract][Full Text] [Related]
19. Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.
Anadón A; Martinez-Larrañaga MR; Fernandez MC; Diaz MJ; Bringas P
Antimicrob Agents Chemother; 1990 Nov; 34(11):2148-51. PubMed ID: 2073104
[TBL] [Abstract][Full Text] [Related]
20. Microsomal enzyme induction by permethrin in rats.
Anadon A; Diez MJ; Sierra M; Sanchez JA; Teran MT
Vet Hum Toxicol; 1988 Aug; 30(4):309-12. PubMed ID: 2902710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
